News / Events

EliRoam: User testing begins at the Budapest Zoo

The user testing phase of EliRoam, our portable immunoassay solution for non-invasive hormone monitoring, has started at the Budapest Zoo & Botanical Garden. The zoo team will analyse samples from Angele the elephant and Banu the Persian leopard to follow changes in their progesterone levels. Feedback and suggestions from the zoo will be built into the further development of the product, supporting the care of endangered species. We are grateful to the Budapest Zoo for their trust and collaboration.

Angele, the elephant at the Budapest Zoo
Angele the elephant. Source: allatkertialapitvany.hu
Banu, the Persian leopard at the Budapest Zoo
Banu the Persian leopard. Source: allatkertialapitvany.hu
Learn more on the EliRoam page →

Vet-Inno TTC PoC Workshop: last week of October

Vet-Inno TTC will hold its Proof-of-Concept (PoC) workshop in the last week of October. The programme includes talks on how the TTC works and on previous PoC projects, as well as a session designed for new applicants, where the 2026 PoC call for applications will also be announced.

Anyone interested is welcome to check back on our website for further details.

Learn more about the PoC program on the Technology Transfer page →

Mosaicplasty in Colorado: Hungarian technology in the equestrian world

This spring, Prof. Gábor Bodó, head of the Department and Clinic of Equine Medicine, was invited to Colorado State University to perform a demonstration surgery — showcasing the equine-adapted mosaicplasty technique. The patient, Lenny, a 4-year-old Quarter Horse being treated for a knee joint cyst, is recovering well and progressing through rehabilitation.

Read the full story and see photos on the Horse Mosaicplasty project page →

PreconCell at ESHRE 2026: international partner search for global market entry

Vet-Inno TTC’s scientific advisor Dr. Csaba Pribenszky presented PreconCell™ at the 42nd Annual Meeting of ESHRE (European Society of Human Reproduction and Embryology) in London, July 5–8, 2026 — the largest international event in reproductive medicine and embryology. The goal was to explore market opportunities and regulatory considerations, and to identify strategic partners for bringing the technology to the human IVF market. Conversations with CooperSurgical and Nexpring provided valuable market insight, and the most promising partnership discussions are ongoing with three companies: MiniTube (Germany), ASTEC (Japan), and VitaVitro (China).

Learn more on the PreconCell project page →